| Style | Citing Format |
|---|---|
| MLA | Darbasizadeh B, Feyzibarnaji B, Naderi N. "Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies." Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance, vol. , no. , 2022, pp. 701-732. |
| APA | Darbasizadeh B, Feyzibarnaji B, Naderi N (2022). Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies. Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance, (), 701-732. |
| Chicago | Darbasizadeh B, Feyzibarnaji B, Naderi N. "Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies." Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance , no. (2022): 701-732. |
| Harvard | Darbasizadeh B, Feyzibarnaji B, Naderi N (2022) 'Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies', Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance, (), pp. 701-732. |
| Vancouver | Darbasizadeh B, Feyzibarnaji B, Naderi N. Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies. Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance. 2022;():701-732. |
| BibTex | @article{ author = {Darbasizadeh B and Feyzibarnaji B and Naderi N}, title = {Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies}, journal = {Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance}, volume = {}, number = {}, pages = {701-732}, year = {2022} } |
| RIS | TY - JOUR AU - Darbasizadeh B AU - Feyzibarnaji B AU - Naderi N TI - Toxicity and Biocompatibility of Nanomaterials: In Vivo Studies JO - Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance VL - IS - SP - 701 EP - 732 PY - 2022 ER - |